Norgine to co-develop personalized fecal incontinence product
This article was originally published in Clinica
Executive Summary
Norgine and Austrian biotech Innovacell have entered into an exclusive licensing and collaboration agreement for the personalized cell-based fecal incontinence product ICEF15. Financial terms were not disclosed.